BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29468960)

  • 1. The Discovery of Antibacterial Natural Compound Based on Peptide Deformylase.
    Liang L; Zhou Q; Hao Z; Wang F; Zhu Y; Lin Q; Gao J
    Comb Chem High Throughput Screen; 2018; 21(4):292-297. PubMed ID: 29468960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
    Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Biological Evaluation of Vanillin Hydroxamic Acid Derivatives as Novel Peptide Deformylase Inhibitors.
    Gao J; Qiu S; Liang L; Hao Z; Zhou Q; Wang F; Mou J; Lin Q
    Curr Comput Aided Drug Des; 2018; 14(1):95-101. PubMed ID: 28606047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
    Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual Screening Approach of Bacterial Peptide Deformylase Inhibitors Results in New Antibiotics.
    Merzoug A; Chikhi A; Bensegueni A; Boucherit H; Okay S
    Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel potent bicyclic peptide deformylase inhibitors.
    Molteni V; He X; Nabakka J; Yang K; Kreusch A; Gordon P; Bursulaya B; Warner I; Shin T; Biorac T; Ryder NS; Goldberg R; Doughty J; He Y
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1477-81. PubMed ID: 15006385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Peptide deformylase inhibition of cyano substituted biaryl analogs: Synthesis, in vitro biological evaluation, molecular docking study and in silico ADME prediction.
    Khan FA; Patil RH; Shinde DB; Sangshetti JN
    Bioorg Med Chem; 2016 Aug; 24(16):3456-63. PubMed ID: 27269198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of FR198248, a hydroxylated 1,3-dihydroisobenzofuran, from Aspergillus flavipes as an inhibitor of peptide deformylase.
    Kwon YJ; Zheng CJ; Kim WG
    Biosci Biotechnol Biochem; 2010; 74(2):390-3. PubMed ID: 20139618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial Peptide Deformylase Inhibition of Tetrazole-Substituted Biaryl Acid Analogs: Synthesis, Biological Evaluations, and Molecular Docking Study.
    Khan FA; Patil RH; Patil M; Arote R; Shinde DB; Sangshetti JN
    Arch Pharm (Weinheim); 2016 Dec; 349(12):934-943. PubMed ID: 27859538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery.
    Sangshetti JN; Khan FA; Shinde DB
    Curr Med Chem; 2015; 22(2):214-36. PubMed ID: 25174923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphenyl tetrazole-thiazolidinediones as novel bacterial peptide deformylase inhibitors: Synthesis, biological evaluations and molecular docking study.
    Khan FAK; Jadhav KS; Patil RH; Shinde DB; Arote RB; Sangshetti JN
    Biomed Pharmacother; 2016 Oct; 83():1146-1153. PubMed ID: 27551762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.
    Kwon YJ; Sohn MJ; Kim CJ; Koshino H; Kim WG
    J Nat Prod; 2012 Feb; 75(2):271-4. PubMed ID: 22329646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
    Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
    Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.
    Spletstoser JT; Dreabit J; Knox AN; Benowitz A; Campobasso N; Ward P; Cui G; Lewandowski T; McCloskey L; Aubart KM
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2410-2414. PubMed ID: 31160176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of 4'-((5-benzylidene-2,4-dioxothiazolidin-3-yl)methyl)biphenyl-2-carbonitrile analogs as bacterial peptide deformylase inhibitors.
    Khan FA; Patil RH; Shinde DB; Sangshetti JN
    Chem Biol Drug Des; 2016 Dec; 88(6):938-944. PubMed ID: 27401234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.
    Min S; Ingraham K; Huang J; McCloskey L; Rilling S; Windau A; Pizzollo J; Butler D; Aubart K; Miller LA; Zalacain M; Holmes DJ; O'Dwyer K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4644-52. PubMed ID: 26014938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide deformylase as an antibacterial target: a critical assessment.
    Leeds JA; Dean CR
    Curr Opin Pharmacol; 2006 Oct; 6(5):445-52. PubMed ID: 16904375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
    Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.